Dataset from A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM)

The current study investigates colesevelam as add-on therapy to pioglitazone to improve
glycemic control in subjects with type 2 diabetes mellitus not adequately controlled with
pioglitazone monotherapy or pioglitazone in combination with either metformin or a
sulfonylurea. The study will evaluate if colesevelam add-on to pioglitazone therapy for type
2 diabetes mellitus will be safe, well tolerated, and efficacious.